Testing effectiveness (Phase 2)Study completedNCT00058487What this trial is testingEpirubicin and Thalidomide in Treating Patients With Liver CancerWho this might be right forLiver Cancer Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00077441What this trial is testingBortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)Who this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00085410What this trial is testingBortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or GallbladderWho this might be right forAdenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01005199What this trial is testingSorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver CancerWho this might be right forLiver Cancer Swiss Cancer Institute 106
Large-scale testing (Phase 3)Study completedNCT00304135What this trial is testingFluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Federation Francophone de Cancerologie Digestive 34
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00003907What this trial is testingChemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the LiverWho this might be right forLiver CancerMetastatic Cancer Eastern Cooperative Oncology Group 50
Early research (Phase 1)Study completedNCT00093444What this trial is testingHeat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver TumorsWho this might be right forLiver CancerMetastatic Cancer National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00073905What this trial is testingAdjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more Swiss Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT00083226What this trial is testingDoxorubicin and Bortezomib in Treating Patients With Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Not applicableStudy completedNCT00482365What this trial is testingNational Registry and Blood Bank of Patients With Liver CancerWho this might be right forLiver Cancer Vanderbilt-Ingram Cancer Center 151
Testing effectiveness (Phase 2)Ended earlyNCT01079767What this trial is testingTemsirolimus in Treating Patients With Advanced Liver Cancer and CirrhosisWho this might be right forLiver Cancer Federation Francophone de Cancerologie Digestive 6
Early research (Phase 1)Ended earlyNCT00873002What this trial is testingPanobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by SurgeryWho this might be right forLiver Cancer Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT00003714What this trial is testingChemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney CancerWho this might be right forLiver CancerMetastatic Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01229111What this trial is testingCediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersWho this might be right forAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT01425879What this trial is testingMK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryWho this might be right forAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00777894What this trial is testingRadiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forLiver Cancer Swiss Cancer Institute 18